NCT01467596

Brief Summary

The aim of this study is to determine the minimum effective volume of local anesthetic (50:50 mixture of 0.5% levobupivacaine and 2% lidocaine) required to produce an effective US-SCB for surgical anesthesia in 50% of patients and to calculate the effective volume required to produce an effective US-SCB in 95% of the patients (MEAV95) in elderly group (\>65 years) and in middle aged group (\<45years) of patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2011

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

November 4, 2011

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 8, 2011

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

November 15, 2012

Status Verified

November 1, 2012

Enrollment Period

1 year

First QC Date

November 4, 2011

Last Update Submit

November 14, 2012

Conditions

Keywords

UltrasoundBrachial blockLevobupivacaineMinimumVolumeMinimum volume of Levobupivacaine 0,5%

Outcome Measures

Primary Outcomes (1)

  • Ultrasound-guided Supraclavicular Brachial Plexus Block in Elderly

    Determining the minimum effective volume of a 50:50 mixture of levobupivacaine 0.5% and lidocaine 2% for successful supraclavicular brachial plexus block for hand surgery in 50% of elderly patients (MEAV50) and to calculate the effective volume in 95% of the elderly patients (MEAV95) as compared with control group (middle aged patients).

    A blinded Assistant assess sensory and motor blockade in a 5-min intervals up to 30 minutes

Secondary Outcomes (1)

  • Ultrasound-guided Supraclavicular Brachial Plexus Block in...

    A blinded Assistant assess onset (in a 5-min intervals up to 30 minutes after completion of US-SCB) ) and duration of sensory and motor blockade (in a 30-min intervals after the completion of surgery).

Study Arms (2)

Elderly population

EXPERIMENTAL

MEAV50, MEAV95 Onset and duration of sensory and motor blockade

Device: Elderly population, Middle aged population

Middle aged population

ACTIVE COMPARATOR

MEAV50, MEAV95 Onset and duration of sensory and motor blockade

Device: Elderly population, Middle aged population

Interventions

The study method is a step-up/step-down sequence model where the dose of local anesthetic for the following patient is determined by the outcome of the preceding block. The starting dose of 50:50 mixture of 0.5% levobupivacaine and 2% lidocaine is 30 mL. In the case of block failure, the dose will be increased by 5 mL. Conversely, block success will result in a reduction in dose by 5 mL. A blinded assistant will assess sensory and motor blockade in each nerve territory ( the median, radial, ulnar and musculocutaneous) at 5-min intervals up to 30 min after completion of US-SCB. Effective US-SCB will be defined as complete sensory blockade in the distribution of the radial, ulnar, median and musculocutaneous nerve.

Also known as: Levobupivacaine 0.5%, Lidocaine 2%
Elderly populationMiddle aged population

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA 1 - 3 elderly patients (\>65 years) scheduled for hand surgery
  • ASA 1-3 middle aged patients (\<45 years)

You may not qualify if:

  • Cognitive impairment
  • Coagulopathy
  • Allergy to local anesthetics
  • Infection at the puncture site,
  • Body mass index \> 35 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital Merkur

Zagreb, City of Zagreb, 10000, Croatia

Location

University Hospital Merkur

Zagreb, Croatia, 10000, Croatia

Location

Related Publications (1)

  • Tomulic K, Pavicic Saric J, Acan I.Effect of age on anaesthetic volume for ultrasound guided supraclavicular brachial plexus block: 8AP2-8 June 2011 - Volume 28 - Issue - p 113 European Journal of Anaesthesiology

    RESULT

MeSH Terms

Conditions

Arm Injuries

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Jadranka Pavičić Šarić, MD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDIV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Effects of Age on Minimum Effective Volume of Local Anesthetic for Ultrasound-guided Supraclavicular Brachial Plexus Block (US-SCB)

Study Record Dates

First Submitted

November 4, 2011

First Posted

November 8, 2011

Study Start

November 1, 2011

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

November 15, 2012

Record last verified: 2012-11

Locations